Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertram Pitt

Showing results (181-190 of 687) with videos related to

Pageof 69
Sort By:
American Heart Journal|June 5, 2017
True rate of mineralocorticoid receptor antagonists-related hyperkalemia in placebo-controlled trials: A meta-analysisDavor Vukadinović, Daniel Lavall, Aleksandra Nikolovska Vukadinović, et al.
European Heart Journal|April 11, 2025
Aldosterone-targeted therapies: early implementation in resistant hypertension and chronic kidney diseaseMasatake Kobayashi, Bertram Pitt, João Pedro Ferreira, et al.
Hypertension (Dallas, Tex. : 1979)|July 24, 2013
Complete renin-angiotensin-aldosterone system (RAAS) blockade in high-risk patients: recent insights from renin blockade studiesSanjay Rajagopalan, George L Bakris, William T Abraham, et al.
Journal of Cardiac Failure|January 30, 2008
The relationship between anemia, change in hematocrit over time and change in health status in patients with heart failure after myocardial infarctionMikhail Kosiborod, Harlan M Krumholz, Philip G Jones, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 18, 2022
Repurposing low-dose naltrexone for the prevention and treatment of immunothrombosis in COVID-19Bertram Pitt, Ashley M Tate, David Gluck, et al.
Handbook of Experimental Pharmacology|November 11, 2016
Steroidal and Novel Non-steroidal Mineralocorticoid Receptor Antagonists in Heart Failure and Cardiorenal Diseases: Comparison at Bench and BedsidePeter Kolkhof, Frederic Jaisser, So-Young Kim, et al.
Cardiology|July 19, 2006
FDA and CPMP rulings on subgroup analysesAldo P Maggioni, Bernadette Darne, Dan Atar, et al.
Trends in Endocrinology and Metabolism: TEM|February 25, 2015
Emerging cardiovascular indications of mineralocorticoid receptor antagonistsYasir Parviz, Javaid Iqbal, Bertram Pitt, et al.
JACC. Heart Failure|November 7, 2015
Prognostic Value of Estimated Plasma Volume in Heart FailureKévin Duarte, Jean-Marie Monnez, Eliane Albuisson, et al.
European Heart Journal|October 5, 2011
The impact of the coronary collateral circulation on mortality: a meta-analysisPascal Meier, Harry Hemingway, Alexandra J Lansky, et al.
Pageof 69

Showing results (181-190 of 687) with videos related to

Sort By:
Pageof 69
American Heart Journal|June 5, 2017
True rate of mineralocorticoid receptor antagonists-related hyperkalemia in placebo-controlled trials: A meta-analysisDavor Vukadinović, Daniel Lavall, Aleksandra Nikolovska Vukadinović, et al.
European Heart Journal|April 11, 2025
Aldosterone-targeted therapies: early implementation in resistant hypertension and chronic kidney diseaseMasatake Kobayashi, Bertram Pitt, João Pedro Ferreira, et al.
Hypertension (Dallas, Tex. : 1979)|July 24, 2013
Complete renin-angiotensin-aldosterone system (RAAS) blockade in high-risk patients: recent insights from renin blockade studiesSanjay Rajagopalan, George L Bakris, William T Abraham, et al.
Journal of Cardiac Failure|January 30, 2008
The relationship between anemia, change in hematocrit over time and change in health status in patients with heart failure after myocardial infarctionMikhail Kosiborod, Harlan M Krumholz, Philip G Jones, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 18, 2022
Repurposing low-dose naltrexone for the prevention and treatment of immunothrombosis in COVID-19Bertram Pitt, Ashley M Tate, David Gluck, et al.
Handbook of Experimental Pharmacology|November 11, 2016
Steroidal and Novel Non-steroidal Mineralocorticoid Receptor Antagonists in Heart Failure and Cardiorenal Diseases: Comparison at Bench and BedsidePeter Kolkhof, Frederic Jaisser, So-Young Kim, et al.
Cardiology|July 19, 2006
FDA and CPMP rulings on subgroup analysesAldo P Maggioni, Bernadette Darne, Dan Atar, et al.
Trends in Endocrinology and Metabolism: TEM|February 25, 2015
Emerging cardiovascular indications of mineralocorticoid receptor antagonistsYasir Parviz, Javaid Iqbal, Bertram Pitt, et al.
JACC. Heart Failure|November 7, 2015
Prognostic Value of Estimated Plasma Volume in Heart FailureKévin Duarte, Jean-Marie Monnez, Eliane Albuisson, et al.
European Heart Journal|October 5, 2011
The impact of the coronary collateral circulation on mortality: a meta-analysisPascal Meier, Harry Hemingway, Alexandra J Lansky, et al.
Pageof 69